These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38800761)

  • 1. Mortality, morbidity, and predictors of death among amphetamine-type stimulant users - a longitudinal, nationwide register study.
    Åhman A; Karlsson A; Berge J; Håkansson A
    Addict Behav Rep; 2024 Jun; 19():100553. PubMed ID: 38800761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
    Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.
    Westover AN; Nakonezny PA; Halm EA; Adinoff B
    Addiction; 2018 May; 113(5):857-867. PubMed ID: 29215762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments.
    Vivolo-Kantor AM; Hoots BE; Seth P; Jones CM
    Drug Alcohol Depend; 2020 Nov; 216():108323. PubMed ID: 33032064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up.
    Fridell M; Bäckström M; Hesse M; Krantz P; Perrin S; Nyhlén A
    BMC Psychiatry; 2019 May; 19(1):150. PubMed ID: 31092225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among amphetamine users with hepatitis C virus infection: A nationwide study.
    Gahrton C; Håkansson A; Kåberg M; Jerkeman A; Häbel H; Dalgard O; Duberg AS; Aleman S
    PLoS One; 2021; 16(6):e0253710. PubMed ID: 34166475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
    Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G
    Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis.
    Vu NT; Maher L; Zablotska I
    J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.
    Harada T; Tsutomi H; Mori R; Wilson DB
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011315. PubMed ID: 30577083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidity and risk of premature mortality and suicide among those with chronic respiratory diseases, cardiovascular diseases, and diabetes in Sweden: A nationwide matched cohort study of over 1 million patients and their unaffected siblings.
    Sariaslan A; Sharpe M; Larsson H; Wolf A; Lichtenstein P; Fazel S
    PLoS Med; 2022 Jan; 19(1):e1003864. PubMed ID: 35085232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
    Gjersing L; Bretteville-Jensen AL
    Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of drug use and depressive symptoms among amphetamine type stimulants users in Beijing and Guangdong province, China.
    Bao YP; Qiu Y; Yan SY; Jia ZJ; Li SX; Lian Z; Mu Y; Liu ZM
    PLoS One; 2013; 8(4):e60544. PubMed ID: 23585838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and causes of death among people who inject amphetamine: A long-term follow-up cohort study from a needle exchange program in Sweden.
    Åhman A; Jerkeman A; Blomé MA; Björkman P; Håkansson A
    Drug Alcohol Depend; 2018 Jul; 188():274-280. PubMed ID: 29803034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-type stimulants use and socio-economic factors associated with hepatitis C antibody positivity among border drug users in South of China.
    Li J; Li M; Zhang Y; Li J; Zhao Y; Lu R; You J
    Front Public Health; 2022; 10():998768. PubMed ID: 36388362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.
    Harada T; Tsutomi H; Mori R; Wilson DB
    Campbell Syst Rev; 2019 Jun; 15(1-2):e1026. PubMed ID: 37131466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.
    Sun S; Kuja-Halkola R; Faraone SV; D'Onofrio BM; Dalsgaard S; Chang Z; Larsson H
    JAMA Psychiatry; 2019 Nov; 76(11):1141-1149. PubMed ID: 31389973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China.
    Bao YP; Liu ZM; Lian Z; Li JH; Zhang RM; Zhang CB; Hao W; Wang XY; Zhao M; Jiang HF; Yan SY; Wang QL; Qu Z; Zhang HR; Wu P; Shi J; Lu L
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):438-46. PubMed ID: 22481605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
    Martens MS; Zurhold H; Rosenkranz M; O'Donnell A; Addison M; Spencer L; McGovern W; Gabrhelík R; Petruželka B; Rowicka M; Liebregts N; Degkwitz P; Kaner E; Verthein U
    Harm Reduct J; 2020 Jan; 17(1):8. PubMed ID: 31931819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.